|
Delayed
OTC Markets
11:45:13 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 0.000800 USD | +166.67% |
|
+166.67% | +300.00% |
| 24-09-10 | Tyra Biosciences Names Doug Warner Chief Medical Officer | MT |
| 24-07-07 | EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.76K | - | - | - | - | - |
| 68.21B | |||||
| 64.25B | |||||
| 26.54B | - | ||||
| 25.61B | - | ||||
| 19.88B |
Select your edition
All financial news and data tailored to specific country editions
